januari
decemb
test
sampl
patient
bernhardnocht
institut
tropic
medicin
hamburg
germani
chikv
infect
symptom
compat
acut
recent
chikv
infect
sudden
onset
fever
muscl
joint
pain
headach
rash
upon
return
europ
germani
n
belgium
n
switzerland
n
denmark
n
poland
n
patient
exact
travel
destin
report
madagascar
n
mauritiu
n
seychel
n
island
n
bali
n
indonesia
n
sri
lanka
n
india
n
malaysia
n
kenya
n
thailand
n
averag
age
travel
countri
differ
significantli
analysi
varianc
ftest
p
patient
exact
date
onset
sampl
could
retriev
voluntari
questionnair
complet
telephon
fax
issuanc
result
age
sex
distribut
travel
histori
patient
shown
tabl
day
onset
symptom
defin
day
sampl
possibl
chikv
test
igg
igm
indirect
immunofluoresc
first
half
sampl
test
realtim
rtpcr
addit
howev
second
half
year
rtpcr
test
restrict
sampl
patient
acut
infect
basi
experi
first
month
describ
classif
patient
laboratoryconfirm
case
requir
either
posit
rtpcr
igm
result
isol
igg
detect
least
subsequ
increas
titer
statgraph
plu
softwar
packag
manugist
dresden
germani
use
statist
analys
chikv
strain
grown
vero
cell
multipl
infect
cell
spread
slide
h
air
dri
fix
icecold
aceton
serum
sampl
incub
h
igg
overnight
igm
fix
cell
antibodi
detect
antihuman
igg
igm
label
fluorescein
isothiocyan
sifin
berlin
germani
igm
test
igg
absorb
test
biosorb
resin
biom
munich
germani
specif
antibodi
confirm
plaquereduct
neutral
assay
select
sampl
data
shown
two
version
realtim
rtpcr
target
chikv
use
chikv
gener
adapt
specif
current
epidem
strain
reaction
condit
oligonucleotid
list
tabl
quantifi
rna
gener
clone
rtpcr
target
region
plasmid
invitrogen
karlsruh
germani
insert
togeth
promotor
sequenc
amplifi
plasmidspecif
primer
transcrib
rna
use
megascript
reagent
ambion
austin
tx
usa
dnase
digest
affin
purif
transcript
quantifi
photomet
use
quantif
standard
competit
intern
control
gener
overlapextens
pcr
describ
use
chikschika
primer
mutagen
primer
mutat
construct
clone
transcrib
rna
assay
crossreact
rna
extract
serum
sampl
high
titer
undilut
cell
cultur
supernat
follow
virus
barmah
forest
dengu
epsteinbarr
hepat
c
herp
simplex
type
human
immunodefici
type
japanes
enceph
poliomyel
type
ross
river
sindbi
venezuelan
equin
encephalt
west
nile
yellow
fever
accord
seri
parallel
limitingdilut
experi
probit
analysi
gener
chikv
assay
detect
rna
copiesml
serum
certainti
confid
interv
ci
copiesml
assay
adapt
current
indian
ocean
strain
detect
copiesml
certainti
ci
copiesml
onlin
appendix
avail
whole
panel
clinic
sampl
describ
studi
quantit
correl
assay
close
regress
analysi
slope
sd
p
onlin
appendix
avail
fragment
chikv
gene
posit
genbank
access
amplifi
directli
patient
plasma
sequenc
sequenc
perform
ceq
genet
analysi
system
beckman
coulter
krefield
germani
recommend
sequenc
analyz
lasergen
softwar
packag
dnastar
madison
wi
usa
serum
sampl
test
dengu
antibodi
igm
assay
panbio
sinnamon
park
queensland
australia
indirect
igg
immunofluoresc
assay
describ
sampl
reportedli
taken
first
day
ill
also
test
dengu
viru
realtim
rtpcr
chikv
infect
laboratoryconfirm
symptomat
patient
sampl
median
igg
titer
iggposit
sampl
rang
median
igm
titer
igmposit
sampl
rang
median
viral
load
rna
posit
sampl
rna
copiesml
rang
rna
copiesml
tabl
summar
crosssect
test
result
individu
patient
time
first
visit
first
half
year
rate
confirm
infect
patient
suspect
chikv
second
half
although
number
laboratori
test
compar
first
second
half
year
vs
laboratori
confirm
rate
travel
significantli
higher
first
half
test
p
abl
retriev
sampl
exact
inform
travel
destin
onset
symptom
date
sampl
patient
figur
chikv
igg
found
patient
sampl
earliest
sampl
detect
igg
titer
drawn
day
onset
latest
day
isol
igg
titer
ie
concomit
igm
detect
sampl
collect
late
onset
median
day
rang
day
remain
sampl
collect
day
posit
rtpcr
demonstr
chikv
igm
found
sampl
patient
earliest
igmposit
result
obtain
sampl
drawn
day
latest
obtain
day
sampl
igm
sampl
concomit
igg
titer
drawn
day
onset
fever
concomitantli
posit
rtpcr
patient
whose
first
sampl
yield
antibodi
consecut
sampl
avail
pair
sampl
drawn
least
day
apart
first
sampl
collect
median
day
onset
rang
day
igm
median
titer
igg
median
titer
second
sampl
collect
median
day
onset
rang
day
median
igg
titer
median
igm
titer
patient
igm
detect
second
serum
sampl
earliest
drawn
day
onset
symptom
patient
complet
histori
posit
realtim
rtpcr
result
compar
effici
diagnost
method
acut
diseas
select
sampl
collect
first
day
symptom
patient
chikv
confirm
viru
isol
subsequ
seroconvers
n
rtpcr
posit
day
regardless
antibodi
result
figur
igg
igm
posit
day
onward
igm
detect
day
earlier
igg
overlap
rtpcr
antibodi
result
occur
day
posit
rtpcr
result
found
day
assess
whether
chikv
rna
detect
may
influenc
antivir
antibodi
compar
rna
concentr
seroneg
n
seroposit
n
sampl
collect
within
first
day
ill
figur
median
rna
concentr
copiesml
seroneg
sampl
significantli
higher
copiesml
found
median
concentr
seroposit
sampl
p
analysi
varianc
ftest
character
cours
viremia
absenc
antibodi
plot
viral
load
antibodyneg
pcrposit
sampl
sampl
day
highest
concentr
found
sampl
drawn
day
mean
rna
copiesml
ci
copiesml
figur
viral
load
later
sampl
continu
decreas
reassess
diagnost
valu
classic
viru
isol
techniqu
cultur
pcrposit
serum
sampl
vero
cell
materi
frozen
thaw
time
cell
cultur
sampl
yield
viru
isol
viru
isol
sampl
contain
rna
copiesml
figur
cultureposit
sampl
taken
second
day
fever
mean
day
onset
antibodi
detect
sampl
suggest
infect
cultur
may
neutral
antibodi
dengu
viru
endem
part
indian
ocean
region
resembl
chikv
infect
serum
sampl
receiv
first
half
includ
patient
travel
diseas
histori
incomplet
test
dengu
viru
patient
dengu
igg
dengu
igm
antibodi
without
igg
found
addit
patient
suggest
acut
infect
patient
travel
mauritiu
one
patient
dengu
igm
chikv
rna
patient
long
period
fever
day
sever
arthralgia
anoth
patient
dengu
igm
antichikv
viru
igm
igg
patient
sever
arthralgia
month
sequenc
pcrposit
sampl
show
origin
genotyp
mutat
island
mauritiu
sampl
first
half
sampl
india
n
sri
lanka
n
collect
second
half
display
origin
genotyp
chikv
viral
load
among
genotyp
compar
figur
median
concentr
copiesml
copiesml
significantli
differ
confid
level
exclud
influenc
chikv
antibodi
result
analyz
sampl
without
antibodi
separ
differ
signific
sampl
n
copiesml
sampl
n
rna
copiesml
chikungunya
fever
becom
major
differenti
diagnosi
along
malaria
dengu
fever
ill
travel
return
europ
indian
ocean
region
chikungunya
fever
similar
symptom
requir
differ
manag
malaria
dengu
laboratori
test
chikv
part
routin
clinic
decis
make
analysi
baselin
virolog
find
use
modern
repertoir
diagnost
test
compris
largest
cohort
travel
return
site
current
epidem
tourist
particular
interest
seen
context
commun
outbreak
thu
diagnos
need
individu
laboratori
confirm
larg
number
case
studi
enabl
us
establish
gapless
time
cours
virolog
paramet
cumul
singl
dualpoint
laboratori
determin
individu
infect
travel
crosssect
laboratori
data
provid
good
indic
extent
larg
outbreak
usual
underdiagnos
arboviru
infect
travel
first
half
much
clinic
suspect
case
chikv
infect
could
confirm
predict
valu
clinic
diagnosi
impress
compar
suspect
dengu
viru
infect
travel
decreas
second
half
probabl
reflect
decreas
chikv
activ
tourist
destin
along
shift
indian
subcontin
tourism
less
concentr
cumul
time
cours
antichikv
igg
igm
antibodi
detect
soon
onset
symptom
present
patient
acut
infect
confirm
day
igg
present
earli
addit
test
igm
provid
limit
addit
sensit
detect
acut
case
like
find
caus
low
sensit
igm
assay
unusu
earli
igg
respons
one
reason
earli
igg
find
could
lack
specif
appli
immunofluoresc
assay
howev
shown
recent
indirect
immunofluoresc
sensit
specif
method
determin
antibodi
chikv
n
litzba
et
al
unpub
data
moreov
confirm
specif
immunofluoresc
assay
result
retest
subset
serum
sampl
plaquereduct
neutral
test
data
shown
antibodyposit
sampl
subject
test
posit
result
final
patient
resid
germani
alphavirus
endem
preexist
antibodi
unlik
must
therefor
assum
igg
result
technic
valid
explan
earli
igg
product
would
presenc
unusu
high
presymptomat
viremia
provid
earli
antigen
stimulu
antibodi
format
cell
cultur
studi
particularli
diagnost
rather
insensit
compar
rtpcr
presenc
antibodi
seem
prevent
isol
viru
success
cultur
cytopath
effect
observ
day
incub
often
requir
least
passag
made
time
cultur
longer
time
seroconvers
nevertheless
cultur
essenti
specif
investig
viru
neutral
test
well
ecolog
basic
research
clinic
viru
detect
rtpcr
seem
method
choic
studi
provid
altern
realtim
rtpcr
protocol
analyt
perform
compar
major
diagnost
pcr
system
protocol
clinic
evalu
whole
cohort
apart
practic
diagnost
implic
find
identifi
import
question
futur
research
exampl
cours
antibodi
viremia
differ
dengu
viru
infect
probabl
import
differ
earli
igg
respons
chikv
compar
clear
delay
igg
appear
igm
acut
case
primari
dengu
viru
infect
substanti
fraction
patient
dengu
igg
detect
week
ill
one
could
specul
reason
differ
differ
tropism
viru
dengu
viru
infect
predominantli
monocyt
therebi
may
induc
relev
shortterm
immunosuppress
chikv
probabl
share
tropism
although
primari
target
site
chikv
infect
unclear
whether
coinfect
dengu
chikv
would
lead
alter
symptom
anoth
question
patient
studi
coinfect
diseas
cours
may
sever
prolong
patient
detail
control
studi
patient
need
data
viral
load
determin
studi
crucial
infect
control
first
day
ill
patient
tremend
viru
concentr
sometim
copiesml
plasma
high
viral
load
uncommon
arbovir
diseas
would
make
chikv
prone
nosocomi
transmiss
eg
needlestick
injuri
mucou
membran
exposur
inde
event
alreadi
document
blood
bodi
fluid
chikv
patient
consid
infecti
first
week
symptom
determin
studi
whether
potenti
infect
chikv
may
also
becom
import
context
transfus
analyz
symptomat
patient
howev
viru
concentr
patient
alreadi
decreas
symptom
detect
therefor
high
viremia
presymptomat
patient
seem
like
none
patient
antibodi
day
presymptomat
patient
would
therefor
highli
infecti
issu
transfus
transmiss
chikv
deserv
intens
investig
target
intervent
like
island
blood
donat
suspend
epidem
blood
import
franc
option
india
southeast
asia
larg
epidem
chikv
infect
could
occur
cours
diseas
unusu
sever
unclear
previou
studi
recogn
exchang
envelop
glycoprotein
first
time
chikv
found
increas
time
isol
island
relat
semliki
forest
viru
correspond
mutat
confer
replic
advantag
cholesteroldeplet
insect
cell
viru
would
implic
advantag
reservoir
addit
find
schuffeneck
et
al
could
confirm
presenc
mutat
mauritiu
larger
part
patient
visit
howev
virus
isol
late
phase
studi
septemb
decemb
patient
return
india
sri
lanka
respect
show
mutat
otherwis
clearli
relat
indian
ocean
strain
signific
mutat
thu
remain
uncertain
function
studi
need
confirm
genet
connect
would
provid
anoth
exampl
minor
genet
differ
account
major
chang
arthropod
viru
past
ongo
experi
agent
coronaviru
sever
acut
respiratori
syndrom
avian
influenza
virus
chikv
epidem
provid
proof
import
research
ecolog
emerg
reemerg
diseas
